In vitro studies demonstrate that BDNF, through its receptor TrkB, stimulates high grade glioma cells proliferation (Xiong et al., 2013) and that BDNF release increases with neural activity (Venkatesh et al., 2015). The gene discussed is NTRK2; the disease is glioma.